This enthusiasm for MAFLD histological evaluation is quite relevant, since new therapies are awaited and certainly, the staging of fibrosis and inflammation should help physicians in choosing the best therapeutic approach for their patients. This could delay the progression to cirrhosis and reduce the need for liver transplantation.